
USPH Stock Forecast & Price Target
USPH Analyst Ratings
Bulls say
US Physical Therapy is well-positioned to continue its strong financial performance, with estimated revenue growth of 7% and 5% in 2026 and 2027, respectively. The company has a diverse mix of payment sources, including managed care programs, commercial health insurance, Medicare/Medicaid, and workers' compensation insurance, which ensures stability and a steady stream of revenue. Furthermore, recent results have shown positive trends in key metrics, such as an increase in same-store visits and improved net revenue per patient visit. The company's strategic partnerships with hospital systems also provide potential for significant growth and value creation in the future. While patient and wage pressures may impact profitability, US Physical Therapy's strong financial management, as evidenced by its positive EBITDA and gross margins, positions it well to overcome these challenges and continue delivering solid performance.
Bears say
US Physical Therapy is experiencing mixed results for its Q1, with revenue exceeding expectations but profitability lower than analysts projected. While the company is showing growth in its industrial injury prevention segment, its total operating costs have also increased. Additionally, the recent hospital system partnerships may provide potential upside in the future, but this factor is not yet reflected in the company's valuation. With a lower price target due to sector multiple compression, analysts remain optimistic about the company's growth potential and believe the risk-reward profile is favorable for investors.
This aggregate rating is based on analysts' research of U.S. Physical Therapy and is not a guaranteed prediction by Public.com or investment advice.
USPH Analyst Forecast & Price Prediction
Start investing in USPH
Order type
Buy in
Order amount
Est. shares
0 shares